Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Antinuclear antibodies in pediatric acquired demyelinating diseases of the central nervous system.
Callosal atrophy in multiple sclerosis is related to cognitive speed.
MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
Novel immunoregulatory properties of EGCG on reducing inflammation in EAE.
Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs.
Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells.
Fingolimod protects cultured cortical neurons against excitotoxic death.
Role of Venoplasty for Treatment of Multiple Sclerosis: Value of Open-label Studies and Surrogate Treatment Outcomes.
OnabotulinumtoxinA (Botox(®)): A Review of its Use in the Treatment of Urinary Incontinence in Patients with Multiple Sclerosis or Subcervical Spinal Cord Injury.
Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis?
Immune reconstitution inflammatory syndrome in a patient treated with natalizumab presenting progressive multifocal leukoencephalopathy.
[Transorbital echography for assessment of optical nerve atrophy in demyelinating diseases: a pilot study].
Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial.
siRNA knockdown of ADAM-10, but not ADAM-17, significantly reduces fractalkine shedding following pro-inflammatory cytokine treatment in a human adult brain endothelial cell line.
Assessing the long-term clinical benefit of prolonged-release fampridine tablets in a real-world setting: a review of 67 cases.
Cognitive dysfunction in multiple sclerosis.
Gray matter involvement in multiple sclerosis.
New management algorithms in multiple sclerosis.
Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone.
Vitamin d and multiple sclerosis.
Psychological effects of calisthenic exercises on neuroinflammatory and rheumatic diseases.
Levofloxacin-Induced Delirium in a Patient Suffering from Schizoaffective Disorder and Multiple Sclerosis.
The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.
Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes.
Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia
Pages
« first
‹ previous
…
181
182
183
184
185
186
187
188
189
…
next ›
last »